Your browser doesn't support javascript.
loading
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.
Yndestad, Synnøve; Austreid, Eilin; Knappskog, Stian; Chrisanthar, Ranjan; Lilleng, Peer Kåre; Lønning, Per Eystein; Eikesdal, Hans Petter.
Afiliação
  • Yndestad S; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Austreid E; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Knappskog S; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Chrisanthar R; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Lilleng PK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Lønning PE; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Eikesdal HP; Section of Molecular Pathology, Department of Pathology, Oslo University Hospital, Oslo, Norway.
Breast Cancer Res Treat ; 163(1): 177-190, 2017 May.
Article em En | MEDLINE | ID: mdl-28213783
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Quimioterapia Adjuvante / PTEN Fosfo-Hidrolase Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Quimioterapia Adjuvante / PTEN Fosfo-Hidrolase Idioma: En Ano de publicação: 2017 Tipo de documento: Article